Zoetis Inc. Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection

Reuters

06-02

<a href="https://laohu8.com/S/ZTS">Zoetis Inc.</a> Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection

Zoetis Inc. has unveiled AI Masses, the latest AI-powered analysis technology incorporated into the Vetscan Imagyst® analyzer, enhancing its capabilities in veterinary diagnostics. This new feature provides fast and accurate in-clinic screening of common lymph node and skin/subcutaneous lesions within minutes, supporting veterinary professionals in making informed decisions. The innovative technology streamlines diagnoses and clinic workflows by detecting potentially neoplastic cells with high accuracy. With the addition of AI Masses, Vetscan Imagyst now offers seven unique testing applications, solidifying its position as the most capable veterinary AI analyzer globally. The new capability will be highlighted at the 40th World Veterinary Association Congress in conjunction with the AVMA Convention 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2540442798"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540442798\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2540442798?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-02 20:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540442798","market":"us","top_or_hot":-1,"title":"Zoetis Inc. Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ZTS\">Zoetis Inc.</a> Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zoetis Inc. has unveiled AI Masses, the latest AI-powered analysis technology incorporated into the Vetscan Imagyst® analyzer, enhancing its capabilities in veterinary diagnostics. This new feature provides fast and accurate in-clinic screening of common lymph node and skin/subcutaneous lesions within minutes, supporting veterinary professionals in making informed decisions. The innovative technology streamlines diagnoses and clinic workflows by detecting potentially neoplastic cells with high accuracy. With the addition of AI Masses, Vetscan Imagyst now offers seven unique testing applications, solidifying its position as the most capable veterinary AI analyzer globally. The new capability will be highlighted at the 40th World Veterinary Association Congress in conjunction with the AVMA Convention 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zoetis Inc. Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZoetis Inc. Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-02 20:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ZTS\">Zoetis Inc.</a> Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zoetis Inc. has unveiled AI Masses, the latest AI-powered analysis technology incorporated into the Vetscan Imagyst® analyzer, enhancing its capabilities in veterinary diagnostics. This new feature provides fast and accurate in-clinic screening of common lymph node and skin/subcutaneous lesions within minutes, supporting veterinary professionals in making informed decisions. The innovative technology streamlines diagnoses and clinic workflows by detecting potentially neoplastic cells with high accuracy. With the addition of AI Masses, Vetscan Imagyst now offers seven unique testing applications, solidifying its position as the most capable veterinary AI analyzer globally. The new capability will be highlighted at the 40th World Veterinary Association Congress in conjunction with the AVMA Convention 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL7jBr9m:1","article_id":"2540442798","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540442798","pubTimestamp":1748867676,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zoetis Inc. has unveiled AI Masses, the latest AI-powered analysis technology incorporated into the Vetscan Imagyst analyzer, enhancing its capabilities in veterinary diagnostics. This new feature provides fast and accurate in-clinic screening of common lymph node and skin/subcutaneous lesions within minutes, supporting veterinary professionals in making informed decisions. The innovative technology streamlines diagnoses and clinic workflows by detecting potentially neoplastic cells with high accuracy. With the addition of AI Masses, Vetscan Imagyst now offers seven unique testing applications, solidifying its position as the most capable veterinary AI analyzer globally. The new capability will be highlighted at the 40th World Veterinary Association Congress in conjunction with the AVMA Convention 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"硕腾公司推出AI Masses：兽医细胞学在快速肿瘤细胞检测方面取得突破","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZTS":0.9},"content_text":"Zoetis Inc. Unveils AI Masses: Breakthrough in Veterinary Cytology for Rapid Neoplastic Cell Detection\n    \n\n        Zoetis Inc. has unveiled AI Masses, the latest AI-powered analysis technology incorporated into the Vetscan Imagyst® analyzer, enhancing its capabilities in veterinary diagnostics. This new feature provides fast and accurate in-clinic screening of common lymph node and skin/subcutaneous lesions within minutes, supporting veterinary professionals in making informed decisions. The innovative technology streamlines diagnoses and clinic workflows by detecting potentially neoplastic cells with high accuracy. With the addition of AI Masses, Vetscan Imagyst now offers seven unique testing applications, solidifying its position as the most capable veterinary AI analyzer globally. The new capability will be highlighted at the 40th World Veterinary Association Congress in conjunction with the AVMA Convention 2025.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}